ImmunityBio Inc.
IBRX | NASDAQ
$8.87
+$0.42 (+4.97%)
Sep 22, 2026, 11:42 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -863.19M | -632.78M | -61.96M | -67.27M | -92.56M | -129.67M | -59.18M | -85.75M | -134.58M | -134.13M | -233.41M | -95.58M | -138.21M | -116.58M | -108.33M | -110.94M | -94.59M | -102.83M | -91.26M | -88.43M | -88.29M | -79.61M |
Depreciation & Amortization | 8.79M | 4.38M | 3.87M | 3.95M | 3.88M | 3.83M | 4.14M | 4.44M | 4.41M | 4.56M | 4.56M | 16.04M | 4.68M | 4.68M | 5.23M | 9M | 4.82M | 4.46M | 3.66M | 3.69M | 3.98M | 2.97M |
Stock-Based Compensation | 16.69M | 8.17M | 8.75M | 8.88M | 9.65M | 9.54M | 9.04M | 7.49M | 9.64M | 8.27M | 12.77M | 14.45M | 11.06M | 10.88M | 9.35M | 10.63M | 10.18M | 10.02M | 10.18M | 13.84M | 17.86M | 15.3M |
Other Working Capital | 10.31M | 1.28M | 3.06M | -987K | 3.96M | -13.63M | -3.13M | 2.16M | 3.55M | -8.21M | -22.87M | -4.27M | 10.6M | 27M | -7.03M | 6.35M | -24.14M | 8.82M | -3.24M | -9.16M | -1.99M | -1.01M |
Other Non-Cash Items | 696.77M | 545.37M | -6.62M | -2.13M | 4.84M | 52.43M | -28.3M | -14.89M | 14.83M | 18.22M | 126.55M | -18.04M | 33.64M | -10.96M | 9.62M | 4.36M | 12.49M | 4.6M | 9.02M | 10.11M | -1.17M | 1.89M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -913K | -500K | -14.41M | -12.33M | -5.55M | -22.04M | -10.84M | -10.05M | 5.36M | -3.89M | -25.75M | -4.27M | 9.06M | 27.67M | -6.59M | 6.35M | -24.14M | 8.82M | -3.24M | -11.93M | -1.99M | -1.01M |
Operating Cash Flow | -141.85M | -75.36M | -70.38M | -68.91M | -79.75M | -85.91M | -85.14M | -98.76M | -100.35M | -106.98M | -115.27M | -87.4M | -79.77M | -84.31M | -90.73M | -80.6M | -91.25M | -74.93M | -71.64M | -72.72M | -69.6M | -60.47M |
Capital Expenditures | -5.29M | -1.79M | -1.28M | -775K | -1.08M | -1.12M | -2.11M | -2.79M | -724K | -1.26M | -7.96M | -5.68M | -8.53M | -8.43M | -18.93M | -15.94M | -15.95M | -27.35M | -10.4M | -8.03M | -8.05M | -7.08M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1M | n/a | n/a | n/a | n/a | n/a | 56K | 1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -313.34M | -149.09M | -45.63M | -180.59M | -15.06M | -100K | -6.09M | -747K | -85.77M | -48.36M | -166K | n/a | -78K | -158K | -19K | n/a | n/a | n/a | n/a | -2.48M | n/a | n/a |
Sales Maturities Of Investments | 179.52M | 119.23M | 90.47M | n/a | n/a | 5.35M | 18.03M | 69.57M | 35M | 14M | 10.37M | n/a | n/a | 102K | 56K | n/a | n/a | n/a | n/a | 599K | n/a | n/a |
Other Investing Acitivies | n/a | n/a | -372K | -34K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9.96M | n/a | -56K | -1M | 14.77M | 132.62M | -41.97M | -127.4M | 20.5M | 18.53M | 38.93M |
Investing Cash Flow | -139.12M | -31.65M | 43.57M | -181.36M | -16.14M | 4.13M | 9.83M | 65.03M | -51.49M | -35.62M | 2.25M | -15.63M | -8.6M | -8.48M | -18.89M | -1.17M | 116.67M | -69.31M | -137.8M | 10.58M | 10.49M | 31.85M |
Debt Repayment | 73.23M | 48K | 2.87M | -12K | -4K | n/a | 64K | -22K | -21K | -21K | 192.74M | 198.98M | 29.83M | 29.83M | 49.73M | 124.34M | n/a | n/a | 298.5M | n/a | n/a | 40M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.46M | n/a | n/a | n/a | n/a | n/a | -372K | -480K | n/a | n/a | -2.62M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -7.31M | -7.86M | -1.13M | -151K | -322K | -1.2M | -867K | -299K | 145.29M | 10.25M | -1.56M | 39.99M | 75K | -231K | -219K | -349K | -15K | 74K | 27.93M | 734K | 98.34M | 1.12M |
Financial Cash Flow | 268.37M | 223.93M | 54.89M | 173.52M | 172.81M | -982K | 106.93M | 15.58M | 148.89M | 10.23M | 200.54M | 237.5M | 43.41M | 76.89M | 109.94M | 123.99M | -15K | -298K | 325.95M | 42.66M | 98.34M | 38.5M |
Net Cash Flow | -12.48M | 116.86M | 28.09M | -76.81M | 77M | -82.77M | 31.61M | -18.14M | -2.93M | -132.42M | 87.49M | 134.47M | -44.98M | -16.16M | 480K | 42.26M | 25.66M | -144.72M | 116.58M | -19.43M | 39.28M | 9.76M |
Free Cash Flow | -147.15M | -77.15M | -71.65M | -69.68M | -80.83M | -87.03M | -87.26M | -101.56M | -101.07M | -108.24M | -123.23M | -93.08M | -88.3M | -92.74M | -109.66M | -96.54M | -107.2M | -102.28M | -82.04M | -80.75M | -77.64M | -67.55M |
Adj. Free Cash Flow | -163.83M | -85.32M | -80.4M | -78.56M | -90.48M | -96.56M | -96.29M | -109.04M | -110.71M | -116.51M | -136M | -107.53M | -99.36M | -103.62M | -119.01M | -107.17M | -117.38M | -112.3M | -92.22M | -94.59M | -95.5M | -82.85M |
Maintenance CapEx | -5.29M | -1.79M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.26M | n/a | -5.68M | -6.61M | n/a | -18.93M | n/a | -15.95M | -27.35M | n/a | -8.03M | -8.05M | -7.08M |
Growth CapEx | n/a | n/a | -1.28M | -775K | -1.08M | -1.12M | -2.11M | -2.79M | -724K | n/a | -7.96M | n/a | -1.91M | -8.43M | n/a | -15.94M | n/a | n/a | -10.4M | n/a | n/a | n/a |
Owner Earnings | -147.15M | -77.15M | -70.38M | -68.91M | -79.75M | -85.91M | -85.14M | -98.76M | -100.35M | -108.24M | -115.27M | -93.08M | -86.39M | -84.31M | -109.66M | -80.6M | -107.2M | -102.28M | -71.64M | -80.75M | -77.64M | -67.55M |
Add to Watchlist
Select watchlists to add or remove IBRX